Evidence map›Paper›PMID 34408849›Full record

ArticlePulmonary circulation

Extracellular matrix degradation pathways and fatty acid metabolism regulate distinct pulmonary vascular cell types in pulmonary arterial hypertension.

Sharon Mumby, F Perros, C Hui, B L Xu, W Xu, V Elyasigomari, A Hautefort, G Manaud, M Humbert, K F Chung and 2 more

Open access · goldAbstract read
In one paragraph

Article in Pulmonary circulation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.5field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Review
  3. Beyond classical collagen: basement membrane collagen IV in age-associated lung diseases.European respiratory review : an official journal of the European Respiratory Society · 2025
    Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 5 countries.

Sharon MumbyRespiratory Science, NHLI, Imperial College London, London, UK.
F PerrosUMRS 999, Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique, INSERM and Paris-Sud, Le Plessis Robinson, France.
C HuiCentre for Respiratory & Critical Care Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
B L XuCentre for Respiratory & Critical Care Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
W XuCentre for Respiratory & Critical Care Medicine, The University of Hong Kong-Shenzhen Hospital, Shenzhen, China.
V ElyasigomariDepartment of Computing, Data Science Institute, Imperial College London, London, UK.
A HautefortUMRS 999, Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique, INSERM and Paris-Sud, Le Plessis Robinson, France.
G ManaudUMRS 999, Laboratoire d'Excellence en Recherche sur le Médicament et l'Innovation Thérapeutique, INSERM and Paris-Sud, Le Plessis Robinson, France.
M HumbertDépartement Hospitalo-Universitaire Thorax Innovation, Centre de Référence de l'Hypertension Pulmonaire Sévère, Service de Pneumologie et Réanimation Respiratoire, Hôpital de Bicêtre, Le Kremlin-Bicêtre, France.
K F ChungRespiratory Science, NHLI, Imperial College London, London, UK.
S J WortRespiratory Science, NHLI, Imperial College London, London, UK.
I M AdcockRespiratory Science, NHLI, Imperial College London, London, UK.
Imperial College London · GBNIHR Imperial Biomedical Research Centre · GBUniversity of Hong Kong · HKBicêtre Hospital · FRInserm · FRLaboratoire d'Excellence en Recherche sur le Médicament et l'Innovation ThérapeutiqueUniversité Laval · CAUniversity of Hong Kong - Shenzhen Hospital · CN

Funding

British Heart Foundation PG/14/27/30679
6 · The paper itself

Abstract

Pulmonary arterial hypertension describes a group of diseases characterised by raised pulmonary vascular resistance, resulting from vascular remodelling in the pre-capillary resistance arterioles. Left untreated, patients die from right heart failure. Pulmonary vascular remodelling involves all cell types but to date the precise roles of the different cells is unknown. This study investigated differences in basal gene expression between pulmonary arterial hypertension and controls using both human pulmonary microvascular endothelial cells and human pulmonary artery smooth muscle cells. Human pulmonary microvascular endothelial cells and human pulmonary artery smooth muscle cells from pulmonary arterial hypertension patients and controls were cultured to confluence, harvested and RNA extracted. Whole genome sequencing was performed and after transcript quantification and normalisation, we examined differentially expressed genes and applied gene set enrichment analysis to the differentially expressed genes to identify putative activated pathways. Human pulmonary microvascular endothelial cells displayed 1008 significant (

Indexed as

endothelial cell dysfunctionpulmonary artery smooth muscle cellsRNA-sequencing

Identifiers

PMID34408849
PMCPMC8366141
OpenAlexW3128886659

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.